Vipivotide Tetraxetan consists of a peptide vector linked to a tetraxetan chelator optimized for radiometal coordination in receptor-targeted research. The peptide motif directs binding, while the macrocyclic chelator ensures controlled metal complexation. Researchers assess stability, binding geometry, and solution behavior. Applications include radiometal-ligand modeling, receptor-mapping studies, and chelator-optimization projects.
CAT No: PI-026
CAS No:1702967-37-0
Synonyms/Alias:Vipivotide tetraxetan;PSMA-617;1702967-37-0;PSMA617 TFA;DKFZ-PSMA-617;PSMA617;4YM1W0EGQ5;Vipivotide tetraxetan [INN];Vipivotide tetraxetan [USAN];Vipivotide tetraxetan (PSMA-617);1702967-37-0 (free base);(((S)-1-Carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid;(2S)-2-[[(1S)-1-carboxy-5-[[(2S)-3-naphthalen-2-yl-2-[[4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]methyl]cyclohexanecarbonyl]amino]propanoyl]amino]pentyl]carbamoylamino]pentanedioic acid;(((S)-1-carboxy-5-((S)-3-(naphthalen-2-yl)-2-((1r,4S)-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carboxamido)propanamido)pentyl)carbamoyl)-L-glutamic acid tetra(trifluoroacetic acid);L-Lysine, N2-((((1S)-1,3-dicarboxypropyl)amino)carbonyl)-N6-(3-(2-naphthalenyl)-N-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetyl)-L-alanyl-trans-4-(aminomethyl)cyclohexanecarbonyl)-;N-((N6-(3-(Naphthalen-2-yl)-N-(trans-4-((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)methyl)cyclohexane-1-carbonyl)-L-alanyl)-llysin-N2-yl)carbonyl)-L-glutamic acid;N2-((((1S)-1,3-Dicarboxypropyl)amino)carbonyl)-N6-(3-(2-naphthalenyl)-N-((trans-4-(((2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetyl)amino)methyl)cyclohexyl)carbonyl)-L-alanyl)-L-lysine;Vipivotida tetraxetan;UNII-4YM1W0EGQ5;CHEMBL4594280;SCHEMBL20180896;SCHEMBL21316439;SCHEMBL21501570;GTPL11982;PSMA-617?;Vipivotide tetraxetan (USAN/INN);Vipivotide tetraxetan [USAN:INN];CTC96737;EX-A5885;BDBM50544833;s8670;WHO 11010;AKOS040735693;DA-77204;MS-31892;HY-117410;CS-0065894;D11697;F82270;-LYSINE, N2-((((1S)-1,3-DICARBOXYPROPYL)AMINO)CARBONYL)-N6-(3-(2-NAPHTHALENYL)-N-((TRANS-4-(((2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCLODODEC-1-YL)ACETYL)AMINO)METHYL)CYCLOHEXYL)CARBONYL)--ALANYL)-;PSMA-617; L-Lysine, N2-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]-N6-[3-(2-naphthalenyl)-N-[[trans-4-[[[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]amino]methyl]cyclohexyl]carbonyl]-L-alanyl]-; N2-[[[(1S)-1,3-Dicarboxypropyl]amino]carbony;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More